Japan Non-steroidal Anti-inflammatory Drugs Market (2025-2031) | Segmentation, Competitive Landscape, Analysis, Companies, Outlook, Forecast, Size & Revenue, Trends, Value, Share, Growth, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Japan Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle

3.4 Japan Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces

3.5 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring anti-inflammatory treatment

4.2.2 Growing geriatric population in Japan

4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs

4.3 Market Restraints

4.3.1 Stringent regulations and approvals for new drugs

4.3.2 Side effects associated with prolonged use of non-steroidal anti-inflammatory drugs

4.3.3 Competition from alternative therapies such as physical therapy and acupuncture

6.1 Japan Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.1.4 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.1.5 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F

6.2 Japan Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F

6.2.3 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F

6.2.4 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F

6.2.5 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 Japan Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3.4 Japan Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 Japan Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries

7.2 Japan Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries

8.1 Average number of prescriptions for non-steroidal anti-inflammatory drugs per month

8.2 Patient adherence rate to non-steroidal anti-inflammatory drug treatment regimens

8.3 Number of clinical trials studying the efficacy and safety of non-steroidal anti-inflammatory drugs

8.4 Percentage of healthcare professionals recommending non-steroidal anti-inflammatory drugs for pain management

8.5 Frequency of adverse events reported related to non-steroidal anti-inflammatory drug usage

9.1 Japan Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 Japan Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 Japan Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Japan Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024

10.2 Japan Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters